Bo Baldetorp
Overview
Explore the profile of Bo Baldetorp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
667
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuras M, Betancourt L, Hong R, Szadai L, Rodriguez J, Horvatovich P, et al.
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075679
Background: Melanoma is a highly heterogeneous disease, and a deeper molecular classification is essential for improving patient stratification and treatment approaches. Here, we describe the histopathology-driven proteogenomic landscape of 142...
2.
de Almeida N, Janosi A, Hong R, Rajeh A, Nogueira F, Szadai L, et al.
Clin Transl Med
. 2024 Jul;
14(7):e1773.
PMID: 39032005
No abstract available.
3.
Szadai L, Bartha A, Pla Parada I, Lakatos A, Pal D, Lengyel A, et al.
Front Oncol
. 2024 Jul;
14:1428182.
PMID: 39015503
Introduction: While Immune checkpoint inhibition (ICI) therapy shows significant efficacy in metastatic melanoma, only about 50% respond, lacking reliable predictive methods. We introduce a panel of six proteins aimed at...
4.
Szadai L, Bartha A, Pla Parada I, Lakatos A, Pal D, Lengyel A, et al.
bioRxiv
. 2024 May;
PMID: 38746333
Abstract Figure:
5.
Szadai L, Velasquez E, Szeitz B, de Almeida N, Domont G, Betancourt L, et al.
Cancers (Basel)
. 2021 Dec;
13(23).
PMID: 34885218
The discovery of novel protein biomarkers in melanoma is crucial. Our introduction of formalin-fixed paraffin-embedded (FFPE) tumor protocol provides new opportunities to understand the progression of melanoma and open the...
6.
Betancourt L, Gil J, Kim Y, Doma V, Cakir U, Sanchez A, et al.
Clin Transl Med
. 2021 Jul;
11(7):e473.
PMID: 34323403
The MM500 study is an initiative to map the protein levels in malignant melanoma tumor samples, focused on in-depth histopathology coupled to proteome characterization. The protein levels and localization were...
7.
Betancourt L, Gil J, Sanchez A, Doma V, Kuras M, Murillo J, et al.
Clin Transl Med
. 2021 Jul;
11(7):e451.
PMID: 34323402
The MM500 meta-study aims to establish a knowledge basis of the tumor proteome to serve as a complement to genome and transcriptome studies. Somatic mutations and their effect on the...
8.
Kim Y, Gil J, Pla I, Sanchez A, Betancourt L, Lee B, et al.
Cancers (Basel)
. 2020 Mar;
12(3).
PMID: 32213878
Malignant melanoma is among the most aggressive skin cancers and it has among the highest metastatic potentials. Although surgery to remove the primary tumor is the gold standard treatment, once...
9.
Betancourt L, Szasz A, Kuras M, Murillo J, Sugihara Y, Pla I, et al.
Cancers (Basel)
. 2019 Dec;
11(12).
PMID: 31835364
In comparison to other human cancer types, malignant melanoma exhibits the greatest amount of heterogeneity. After DNA-based detection of the BRAF V600E mutation in melanoma patients, targeted inhibitor treatment is...
10.
Sanchez A, Kuras M, Murillo J, Pla I, Pawlowski K, Szasz A, et al.
Cell Biol Toxicol
. 2019 Oct;
36(3):261-272.
PMID: 31599373
In the advanced stages, malignant melanoma (MM) has a very poor prognosis. Due to tremendous efforts in cancer research over the last 10 years, and the introduction of novel therapies...